Software Engineer Intern
Profluent
Software Engineer Intern
Profluent
AI-designed bespoke proteins for genetic therapies
Profluent is the frontier AI lab for biology. Profluent builds powerful foundation models for all of life's molecules, unlocking solutions that transform medicine, agriculture, and beyond. Founded in 2022 and headquartered in Emeryville, CA, Profluent is backed by leading investors including Altimeter Capital, Bezos Expeditions, Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures and has raised over $150M to date.
We’re looking for a Software Engineering Intern to help build the tools and data systems behind Profluent’s AI-driven protein design cycle. Our models propose new proteins, scientists test them, and experimental results inform what we design next. Your work will help connect those steps and make the resulting data useful for both scientists and machine learning teams.
This is an opportunity to take a focused software project from idea to a tool that scientists use in their research. For example, you might build a tool for exploring protein designs or an interactive dashboard that helps researchers make sense of screening results. You’ll get feedback from the scientists using your work and present what you built at the end of the internship.
NOTICE TO STAFFING AND SEARCH FIRMS: Profluent does not accept unsolicited candidate submissions. We ask that agencies refrain from sending resumes to our careers inbox, hiring managers, or any Profluent employee. Any resume submitted without a signed agreement and an active search request from our Talent team will be treated as the property of Profluent, and no placement fee will be owed.
Profluent.bio designs custom proteins for genetic medicines using artificial intelligence. Its core offering is bespoke protein solutions tailored to therapeutic needs for pharmaceutical and biotech partners, helping advance treatments for genetic diseases. The product works by applying AI to optimize protein design, effectively decoding the “language of life” to create proteins that extend beyond natural or existing patented options. Partners collaborate on projects, with revenue coming from upfront fees, milestones, and royalties on successful commercialization of therapies that use their proteins. The company differentiates itself by combining AI-driven protein design with a partnership model in the gene editing and synthetic biology space, aiming to deliver more effective and precise treatments while enabling cost-efficient development. The goal is to accelerate genetic medicine by providing optimized proteins that enable new or improved therapies for genetic diseases.
Explore more opportunities at Profluent